CRESCENT (OPTI.BR)       0.02  +0 (+1.01%)

0.02  +0 (+1.01%)

BE0003836534 - Common Stock


Fundamental Rating

2

Overall OPTI gets a fundamental rating of 2 out of 10. We evaluated OPTI against 13 industry peers in the Communications Equipment industry. Both the profitability and financial health of OPTI have multiple concerns. OPTI is quite expensive at the moment. It does show a decent growth rate.

Note: OPTI has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

OPTI has a Piotroski-F score of 4.00. This indicates an average health and profitability for OPTI.

VS Industry

Valuation

Valuation Rating

0

When comparing the current price to the book value of OPTI, we can conclude it is valued correctly. It is trading at 3.48 times its book value.
Compared to an average industry price book ratio of 1.67, OPTI is valued more expensive than its industry peers. 91% of the companies listed in the same industry are valued cheaper.

When comparing the Enterprise Value to EBITDA ratio of OPTI to the average industry ratio of 12.18, OPTI is valued more expensive than its industry peers. 80% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (3.48) VS Industry: 9% outperformed.

5.26
0.47

Enterprise Value/ EBITDA (45.81) VS Industry: 20% outperformed.

91.25
2.56

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 28.13% over the past year.
OPTI shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 30.98% yearly.
The Revenue is expected to grow by 18.51% on average over the next 5 years. This is quite good.

OPTI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.65%.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 28.13% N/A N/A N/A N/A
Revenue30.98% -0.9% 7.65% 14.44% 16.3% 18.51% N/A

Health

Health Rating

2

When comparing the Debt to Equity Ratio of 0.11 to an average industry Debt to Equity of 0.17, OPTI is way less dependent on financing that its industry peers.
The Piotroski-F score of OPTI is 4.00. This is a neutral score and indicates average health and profitability for OPTI.
A Current Ratio of 0.56 indicates that OPTI may have some problems paying its short term obligations.
Compared to an average industry Current Ratio of 1.59, OPTI is worse placed to pay its short term obligations than its industry peers. 100% of its industry peers have a better Current Ratio.

A Quick Ratio of 0.42 indicates that OPTI may have some problems paying its short term obligations.
Compared to an average industry Quick Ratio of 1.23, OPTI is worse placed to pay its short term obligations than its industry peers. 100% of its industry peers have a better Quick Ratio.
OPTI has an Altman-Z score of 1.25. This is a bad value and indicates that OPTI is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 1.94, OPTI is in worse financial state than most of its industry peers. 100% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0.11) VS Industry: 72% outperformed.

0.45
0.00

Quick Ratio (0.42) VS Industry: 0% outperformed.

0.42
2.77

Current Ratio (0.56) VS Industry: 0% outperformed.

0.56
3.43

Altman-Z (1.25) VS Industry: 0% outperformed.

1.25
5.79

Dividend

Dividend Rating

0

OPTI does not give a dividend.

CRESCENT0.02

EBR:OPTI (3/29/2023, 7:00:00 PM)+0 (+1.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.88M
Analysts42.22
Price Target0.02 (0%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)-33.33%
PT rev (3m)-33.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.22
P/FCF N/A
P/OCF N/A
P/B 3.48
P/tB N/A
EV/EBITDA 45.81
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0.01
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 36.26%
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.49%
GM growth 5Y-5.67%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 4.82
Cap/Depr 26.67%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.42
Altman-Z 1.25
F-Score4
WACC7.24%
ROIC/WACCN/A
Cap/Depr(3y)60.72%
Cap/Depr(5y)66.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y28.13%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y7.65%
Revenue growth 3Y-0.9%
Revenue growth 5Y30.98%
Revenue growth Q2Q21.6%
Revenue Next Year14.44%
Revenue Next 2Y16.3%
Revenue Next 3Y18.51%
Revenue Next 5YN/A
EBIT growth 1Y42.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year231.7%
EBIT Next 3Y66.72%
EBIT Next 5YN/A
FCF growth 1Y-385.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.36%
OCF growth 3YN/A
OCF growth 5YN/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext